Continuous vs intermittent infusion of beta-lactam antibacterial drugs: impact on resistance and outcomes in sepsis - PMWP 170 (2021–2023)

Grant type:
United States Food and Drug Administration
Researchers:
  • NHMRC Leadership Fellow
    Faculty of Medicine
    Director, UQ Centre for Clinical Re
    Faculty of Medicine
    Director, UQ Centre for Clinical Re
    Faculty of Medicine
    Centre Director of UQ Centre for Cl
    UQ Centre for Clinical Research
    Faculty of Medicine
  • Emeritus/Emerita/Emeritx Professor
    Faculty of Medicine
  • Research Fellow
    Faculty of Medicine
    Research Fellow
    UQ Centre for Clinical Research
    Faculty of Medicine
Funded by:
United States Department of Health and Human Services